Press release
Actinic Keratosis Therapeutics Market Size in the 7MM is projected to grow at a significant CAGR by 2036, estimates DelveInsight
Discover Key Insights into the Actinic Keratosis Market with DelveInsight's In-Depth Report @ https://www.delveinsight.com/sample-request/actinic-keratosis-market [https://www.delveinsight.com/sample-request/actinic-keratosis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Key Takeaways from the Actinic Keratosis Market Report
* On May 22, 2026- Biofrontera Inc . initiated a phase III study is to test the safety. tolerability and efficacy of field-directed photodynamic therapy (PDT) with 10% aminolevulinic acid gel (Ameluz Registered , BF-200 ALA) in combination with one of the narrow spectrum red light RhodoLED lamps in comparison to vehicle treatment for actinic keratosis (AK) on the extremities and neck/trunk.
* On April 22, 2026- Sun Pharmaceutical Industries Inc . conducted a study evaluates the efficacy and safety of reformulated Levulan Kerastick (aminolevulinic acid HCl 20%) combined with photodynamic therapy (PDT) for field-directed treatment of actinic keratosis (AK) on the upper extremities.
* Actinic keratosis is more prevalent in men and older populations.
* The United States represented the largest patient pool among the 7MM, accounting for the majority of diagnosed cases.
* Actinic keratosis has a higher prevalence in fair-skinned individuals.
* Among EU4 and the UK, Germany had the highest number of prevalent cases of actinic keratosis in 2025.
* The leading Actinic Keratosis Companies such as Athenex, Almirall, Vidac Pharma, Promius Pharma and others.
* Promising Actinic Keratosis Therapies such as AVX001, VDA-1102 , Fluorouracil, Imiquimod 3.75% Cream, Tirbanibulin 2.5 mg ointment, KX01 ointment 1%, Tretinoin 0,05% cream, Bimiralisib, Solcera, LAS41005, LAS106521 and others.
Gain insights into drug trends, treatment scenarios, and epidemiological data through our insightful Actinic Keratosis Market Forecast @ Actinic Keratosis Treatment Market [https://www.delveinsight.com/sample-request/actinic-keratosis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Actinic Keratosis Epidemiology Segmentation in the 7MM
* Total Prevalent Cases of Actinic Keratosis
* Total Diagnosed Prevalent Cases of Actinic Keratosis
* Age-specific Cases of Actinic Keratosis
* Gender-specific Cases of Actinic Keratosis
* Total Treated Cases of Actinic Keratosis
Download the Report to understand which factors are driving Actinic Keratosis epidemiology trends @ Actinic Keratosis Prevalence [https://www.delveinsight.com/sample-request/actinic-keratosis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Approved Therapies for Actinic Keratosis
* Tirbanibulin (KLISYRI): Almirall
Tirbanibulin (KLISYRI), ointment 1%, is a microtubule inhibitor indicated for the topical field treatment of actinic keratosis of the face or scalp. It has demonstrated efficacy and safety, with a convenient 5-day application regimen, representing the shortest treatment duration among available topical therapies for actinic keratosis. In December 2020, Almirall announced that the US FDA had approved tirbanibulin for the topical treatment of actinic keratosis of the face or scalp. According to the company's 2025 annual presentation, the net sales of tirbanibulin were approximately USD 38 million for 2025.
* Aminolevulinic acid hydrochloride (AMELUZ): Biofrontera Pharma GmbH
Aminolevulinic acid hydrochloride topical gel, 10% is a photosensitizing agent indicated for the treatment of actinic keratosis of the face and scalp when used in combination with photodynamic therapy (PDT), enabling selective destruction of atypical keratinocytes after light activation. Aminolevulinic acid hydrochloride was initially approved by the US FDA in May 2016 for the treatment of actinic keratosis of the face and scalp in combination with photodynamic therapy. In February 2024, the Medicines and Healthcare products Regulatory Agency (MHRA) and the European Commission approved an extension of the marketing authorization for aminolevulinic acid hydrochloride, allowing its use with artificial daylight photodynamic therapy for the treatment of actinic keratosis. According to the company's FY 2025 results presentation, AMELUZ recorded more than 25% growth in the German market and achieved a market share of approximately 73%.
Actinic Keratosis Pipeline Analysis
* Tuvatexib (VDA-1102): Vidac Pharma
Tuvatexib (VDA-1102) is an investigational topical therapy being developed for the treatment of actinic keratosis. The drug is designed to selectively target abnormal keratinocytes in sun-damaged skin while minimizing effects on surrounding healthy tissue. VDA-1102 works through a novel mechanism of action that dissociates the abnormally overexpressed Hexokinase-2 (HK2) enzyme from the mitochondrial pore, aiming to restore normal cellular metabolism and selectively induce programmed cell death in pathological tissue while sparing healthy cells. The therapy is currently in late-stage of clinical trial (phase II/III).
* RLS-1496: Rubedo Life Sciences
RLS-1496, the lead candidate of Rubedo Life Sciences, is in early clinical trial stage, being developed for topical and oral administration as a potential first-in-class selective GPX4 modulator targeting pathological senescent ("aged") cells involved in chronic degenerative and aging-related conditions, including dermatologic disorders such as actinic keratosis, as well as immunology and inflammation, metabolic diseases, sarcopenia, and neurodegenerative disorders.
Get In-Depth Knowledge on Actinic Keratosis Market Trends and Forecasts with DelveInsight @ Actinic Keratosis Treatment Market [https://www.delveinsight.com/sample-request/actinic-keratosis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Actinic Keratosis Market Outlook
The treatment landscape for actinic keratosis has historically relied on lesion-directed and field-directed therapies aimed at removing visible lesions and treating surrounding sun-damaged skin. Common approaches include cryotherapy, topical agents such as 5-fluorouracil and imiquimod, and photodynamic therapy (PDT). The approved therapy tirbanibulin is a microtubule inhibitor that disrupts cell proliferation and induces apoptosis. Its short 5-day topical regimen represents a meaningful advancement in convenience and adherence compared to older treatments.
Actinic Keratosis Therapies and Companies
* Almirall S.A.: Tirbanibulin 2.5 mg ointment
* PharmaEssentia: KX01 ointment 1%
* Vidac Pharma: 10% VDA-1102
* TORQUR: Bimiralisib
* Infectopharm Arzneimittel GmbH: Solcera
Actinic Keratosis Drugs Landscape
The pipeline for actinic keratosis is evolving with several investigational therapies focusing on improved efficacy, tolerability, and field cancerization management. Tuvatexib is being explored for targeted cytotoxic activity in precancerous skin lesions. Other pipeline agents, including RLS-1496 are under investigation for their potential to provide more selective action, reduced treatment duration, and improved safety profiles compared with existing topical therapies.
Explore comprehensive drug insights and treatment updates in our in-depth Actinic Keratosis Market Forecast @ Actinic Keratosis Clinical Trials Assessment [https://www.delveinsight.com/sample-request/actinic-keratosis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Scope of the Actinic Keratosis Market Report
* Study Period: 2022-2036
* Coverage: 7MM
* Actinic Keratosis Companies- Athenex, Almirall, Vidac Pharma, Promius Pharma and others.
* Actinic Keratosis Therapies- AVX001, VDA-1102 , Fluorouracil, Imiquimod 3.75% Cream, Tirbanibulin 2.5 mg ointment, KX01 ointment 1%, Tretinoin 0,05% cream, Bimiralisib, Solcera, LAS41005, LAS106521 and others.
* Actinic Keratosis Therapeutic Assessment: Actinic Keratosis current marketed and Actinic Keratosis emerging therapies
* Actinic Keratosis Market Dynamics: Actinic Keratosis market drivers and Actinic Keratosis market barriers
* Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
* Actinic Keratosis Unmet Needs, KOLs' views, Analysts' views, Actinic Keratosis Market Access and Reimbursement
Table of Contents
1. Actinic Keratosis Market Report Introduction
2. Executive Summary for Actinic Keratosis
3. SWOT analysis of Actinic Keratosis
4. Actinic Keratosis Patient Share Overview at a Glance
5. Actinic Keratosis Market Overview at a Glance
6. Actinic Keratosis Disease Background and Overview
7. Actinic Keratosis Epidemiology and Patient Population
8. Country-Specific Patient Population of Actinic Keratosis
9. Actinic Keratosis Current Treatment and Medical Practices
10. Actinic Keratosis Unmet Needs
11. Actinic Keratosis Emerging Therapies
12. Actinic Keratosis Market Outlook
13. Country-Wise Actinic Keratosis Market Analysis
14. Actinic Keratosis Market Access and Reimbursement of Therapies
15. Actinic Keratosis Market Drivers
16. Actinic Keratosis Market Barriers
17. Actinic Keratosis Appendix
18. Actinic Keratosis Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=actinic-keratosis-therapeutics-market-size-in-the-7mm-is-projected-to-grow-at-a-significant-cagr-by-2036-estimates-delveinsight]
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/report-store/actinic-keratosis-market
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Actinic Keratosis Therapeutics Market Size in the 7MM is projected to grow at a significant CAGR by 2036, estimates DelveInsight here
News-ID: 4545444 • Views: …
More Releases from ABNewswire
Chris Grose Chiropractic Continues Offering Spinal Decompression Therapy in Beck …
Chris Grose Chiropractic in Beckley, WV, continues offering non-surgical spinal decompression therapy for adults managing herniated discs and spinal conditions. Led by Dr. Chris Grose, the practice uses specialized mechanical traction to gently relieve nerve pressure and support disc recovery. This conservative, drug-free program gives Beckley and Southern West Virginia residents an effective alternative to surgery for chronic back and neck pain.
BECKLEY, WV - Chris Grose Chiropractic continues to provide…
Orchard Manor Expands Nurse-Led Memory Care and Specialized Respite Support in F …
Orchard Manor, a registered-nurse-owned senior living community in Farmington Hills, MI, is expanding its dedicated memory care and short-term respite programs. Designed as an intimate small-group care home, Orchard Manor provides round-the-clock clinical oversight in a warm, domestic setting. The expansion ensures local families have access to compassionate, individualized care for loved ones with memory loss.
FARMINGTON HILLS, MI - As the demand for specialized, low-ratio senior care grows across Oakland…
Digital Product Passports Are Quietly Solving Europe's Biggest Recycling Problem …
Image: http://www.abnewswire.com/pressreleases/wp-content/uploads/2026/07/2026
Circular Plastics Market
Traceability technology is turning contaminated, low-value plastic waste into certified, premium recycled polymer feedstock across the region's packaging, automotive, and electronics sectors.
For many years, the main challenge in plastic recycling wasn't just collecting it, but knowing what was in the waste. A bale of plastic with unknown resin types, unverified additives, or unclear previous use is much less valuable than one with confirmed origins. Now, this traceability…
Why a "Boring" Cooking Oil Is Quietly Becoming Europe's Preferred Industrial Ing …
Image: http://www.abnewswire.com/pressreleases/wp-content/uploads/2026/07/2026
Europe Corn Oil Market
As sunflower oil supply stays volatile, snack and bakery manufacturers are turning to corn oil for its neutral flavor and high smoke point - pushing the Europe Corn Oil Market toward USD 705 million by 2033.
Pune, India - Corn oil seldom receives the same marketing focus as olive or avocado oil, but it doesn't need to. Its strength lies in its neutrality, allowing it to serve…
More Releases for Actinic
Actinic Keratosis Market Emerging Trends and Growth Prospects 2034
Introduction
Actinic keratosis (AK), also known as solar keratosis, is one of the most common precancerous skin conditions caused by long-term ultraviolet (UV) radiation exposure. It primarily affects older adults with fair skin and is considered a precursor to squamous cell carcinoma, making early detection and treatment critical. With rising awareness of skin cancer prevention, growing dermatology consultations, and expanding therapeutic innovations, the global actinic keratosis market is experiencing significant growth.
Over…
Actinic Keratosis Treatment Market Analysis, Size, Share & Trends | 2031
In recent years, the global Actinic Keratosis Treatment Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Actinic Keratosis Treatment Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including…
Global Actinic Keratosis Market Report Forecast to 2027
A rough, scaly area on the skin called an actinic keratosis Market develops after years of sun exposure. It commonly appears on the cheeks, lips, ears, forearms, scalp, neck, and backs of the hands. An actinic keratosis, also known as a sun keratosis, develops slowly and generally appears in persons over the age of 40. By limiting your sun exposure and protecting your skin from ultraviolet (UV) radiation, you…
Actinic Keratosis Market Insight, Epidemiology and Market Forecast -2026
The report studies the global Actinic Keratosis Market with many aspects of the industry like the market size, market status, market trends, and forecast, the report also provides brief information of the competitors and the specific growth opportunities with key market drivers. The report offers valuable insight into the Actinic Keratosis Market progress and approaches related to the market with an analysis of each region. The report goes on to…
Actinic Keratosis Treatment Market Growing Trends and Demands Analysis
The Global Actinic Keratosis Treatment Market is projected to increase at a compound annual growth rate of over 4% between 2018 and 2027. With the increased prevalence of actinic keratosis, demand for its therapeutic medications have also sprung upwards. Actinic keratosis remains an extremely common condition and its existence can be traced all over the world, however people living in countries with thinner ozone layer cover are more prone to…
United States Actinic Keratosis Treatment Market Report 2016
MarketResearchReports.biz has recently announced the addition of a market study “ United States Actinic Keratosis Treatment Market Report 2016 ”, is a comparative analysis of the global market.
Notes:
Sales, means the sales volume of Actinic Keratosis Treatment
Revenue, means the sales value of Actinic Keratosis Treatment
This report studies sales (consumption) of Actinic Keratosis Treatment in United States market, focuses on the top players, with sales, price, revenue and market…
